BOEHRINGER INGELHEIM BIOXCELLENCE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BOEHRINGER INGELHEIM BIOXCELLENCE Trademark

Serial Number: 79127685 • Registration: 4634652

BOEHRINGER INGELHEIM BIOXCELLENCE is a trademark filed by Boehringer Ingelheim Pharma; GmbH & Co. KG on September 14, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 38 (Telecommunications), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Boehringer Ingelheim Pharma GmbH & Co.KG

Binger Straße 173
Ingelheim 55218 , DE

Entity Type: 03

Trademark Details

Filing Date

September 14, 2012

Registration Date

November 11, 2014

Published for Opposition

August 26, 2014

Goods & Services

pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; preparations for destroying vermin; fungicides, herbicides; bacteriological cultures for medical and veterinary purposes as well as culture media for bacteriological cultures; bacteriological preparations for medical and veterinary use for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biological preparations for medical and for veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biochemical preparations for medical and veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; ferments for pharmaceutical purposes; vaccines; culture media for microorganisms; plasters and dressings for medical purposes

Compilation of data in computer databases, in particular in the field of biotechnology and biopharmaceutics; management in connection with the commercialization of technical or scientific results; management relating to the organisation of research; creation, namely, writing and compiling of manufacturing and registration dossiers for pharmaceutical products for third parties; office work, namely, operation of registration proceedings for pharmaceutical products

Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatment in the field of biotechnology; research and development of new products for other sand scientific laboratory services in the field of biotechnology; performance of chemical, biochemical and biological analysis; development of biological, biotechnological and pharmaceutical analysis and their application for others; technical and scientific consultancy, particularly in the field of biotechnology; scientific research; conducting clinical trials for others of pharmaceutical products; providing scientific information via the Internet in the field of pharmaceutical, health care and medical fields; scientific research consulting in the field of pharmaceutical, health care and medical fields

Chemical, biochemical and biological products, substances and preparations for industrial and scientific purposes as well as for research purposes

Printed matter, namely, newspapers, photographs, magazines, books, printed periodicals, newsletters, and brochures all in the field of pharmaceutical preparations; paper; cardboard; goods made from paper and cardboard, namely, boxes of paper and cardboard boxes; cardboard packaging, namely, pharmaceutical packaging; patient record cards and prescription pads; in the field of in the fields of medicine and pharmaceuticals; printed teaching and instructional materials, namely, pharmaceutical information leaflets;books in the fields of medicine and pharmaceuticals; printed publications, namely, magazines, newsletters,pamphlets, reports, instructional and information leaflets, and posters in the fields of medicine and pharmaceuticals; paper packaging, namely, packaging containers of paper; stationery; printed instructional and teaching materials relating to the pharmaceutical, health care and medical fields, in the field of research, medicine, veterinary and laboratory techniques

Custom manufacture of pharmaceuticals, pharmaceutical ingredients, chemical products and chemical intermediates as well as of biological and biochemical products for third parties; treatment of biological materials, namely, batch treatment services with respect to microorganisms and proteins

Medical and veterinary consulting; providing medical and veterinary information via the Internet; all the aforementioned consultations and services also provided through a database; providing medical information via the Internet

[ Transmitting medical and scientific information by means of a database]

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 25, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 7, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 7, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 7, 2025 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Nov 5, 2024 ES75
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 7, 2024 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Jul 16, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 16, 2024 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 14, 2024 INPR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 11, 2023 REM4
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 29, 2023 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Sep 29, 2023 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 18, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Nov 26, 2022 PR71
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 18, 2022 EROP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 17, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 17, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2022 REAP
INTERNATIONAL REGISTRATION RENEWED
Sep 29, 2022 RNWL
POST REGISTRATION ACTION MAILED - SEC.71
May 18, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 21, 2021 APRE
TEAS SECTION 71 RECEIVED
Nov 12, 2020 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 11, 2019 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 3, 2015 FICS
FINAL DISPOSITION PROCESSED
Apr 3, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 11, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2014 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 2, 2014 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 17, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 17, 2014 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Aug 22, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 6, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 23, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2014 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 23, 2014 GPRN
PRIORITY ACTION E-MAILED
Jan 23, 2014 GPRA
PRIORITY ACTION WRITTEN
Jan 23, 2014 CPRA
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
Jan 21, 2014 ZZAX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 20, 2014 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 7, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 7, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 7, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 7, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2014 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 6, 2014 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 21, 2013 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 6, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2013 CNSA
AMENDMENT FROM APPLICANT ENTERED
Nov 20, 2013 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2013 CRFA
ASSIGNED TO LIE
Nov 12, 2013 ALIE
ASSIGNED TO LIE
Nov 1, 2013 ALIE
PAPER RECEIVED
Oct 31, 2013 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2013 TCCA
REFUSAL PROCESSED BY IB
May 19, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 26, 2013 RFCS
REFUSAL PROCESSED BY MPU
Apr 26, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 26, 2013 RFCR
NON-FINAL ACTION WRITTEN
Apr 25, 2013 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Apr 22, 2013 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 20, 2013 RFCR
NON-FINAL ACTION WRITTEN
Apr 19, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 19, 2013 MAFR
ASSIGNED TO EXAMINER
Apr 15, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2013 REPR